AtmosAir Bi-Polar Ionization keeps indoor areas safe

The global solution for healthy air


051023AtmosAir1.jpg

The onset of Covid-19 served as a poignant reminder of the importance of good indoor air quality.

As the country prepares to return to a degree of normalcy and offices begin to reopen, it is of the utmost importance that we are able to secure a safe working environment. While the practice of using masks and vaccines as countermeasures has helped stem the proliferation of the dreaded virus, the threat of the coronavirus continues to linger.

The good news is that science and technology now offers us a new and proven solution to effectively and efficiently combat the spread of the virus.

AtmosAir is USA's leading air purification solution. This approach utilizes bi-polar ionization technology to significantly reduce air-borne bacteria and viruses while producing by products that are toxin-free.

AtmosAir attacks bacteria and viruses in the air and on surfaces using bipolar ionization to damage the molecular structure of the pathogens to effectively neutralize the threat. This is achieved through ionization tubes energizing the air and oxygen around us to form positive and negative air ions which actively seek out contaminants in a given area.

Unlike most air purification systems, AtmosAir is an active technology. It removes contaminants at their source. The system operates in conjunction with ventilation systems. The ventilated space is continuously cleaned and disinfected, making buildings safer and contaminant free.

Independent testing conducted by Microchem Labs has shown that the AtmosAir system is highly effective in neutralizing Coronaviruses in the air and surfaces by 99.92% within 30 minutes. This has led to a significant interest in the use of this technology to make buildings a safer environment to operate from.

051023AtmosAir2.jpg

For more information regarding AtmosAir + ProMedUSA, you may contact DB International Sales and Services, Inc.,  the official exclusive distributor of AtmosAir and ProMED U.S.A. in the Philippines.

430 Lt. Artiaga Street San Juan, Metro Manila, Philippines 1500
Tel. (+632) 8723-4461 to 64
Fax: (+632) 8723-2782, (+632) 8723-4467
email: [email protected]
www.dbiphils.com